Featured Story

The FDA's Banner Year for Drug Approvals — By the Numbers

Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average.

medstuffedited

Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average. Since being sworn in as FDA commissioner in 2017, Scott Gottlieb has made drug approvals a top priority for the agency. In 2018, the FDA made moves to streamline its entire drug approvals process — from early development to final application submissions. And as the country grapples with the issue of drug prices, the FDA has also found ways to significantly shorten the application process for generics and help bring more low-cost alternatives onto the market at a faster clip. Gottlieb recently said that the agency will keep up these efforts in 2019. For…

Full Story

Don't Miss These Pharma Manufacturing Exclusives

Fundamentals

On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Singing the Praises of Lab Safety

    By pharmamanufacturing staff

    The importance of laboratory research to the pharmaceutical industry cannot be overstated. The pharma lab makes essential contributions in product/process development and process improvement, setting the stage for successful scale up and commercialization.To draw attention to these important…

    Full Story
  • The FDA’s Banner Year for Drug Approvals — By the Numbers

    By Meagan Parrish, Senior Editor

    Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average. Since being sworn in as FDA commissioner in 2017, Scott Gottlieb has made drug approvals a top priority for the agency. In 2018, the FDA made moves to streamline its entire drug approvals…

    Full Story
  • Leveraging AI to Drive a Virtuous Cycle Between Drug Development and Application

    By Andrew Carroll, Product Lead, Genomics team at Google Brain and Maria Simbirsky, Sr. Platform Engineer, AI at DNAnexus

    Advances in machine learning and artificial intelligence (AI) are transforming insight across a variety of scientific fields and industries. In this article, we explore the power of these advances to change the way information and analysis are used in drug discovery and biotechnology. We discuss…

    Full Story
  • Top 5 Drugs With the Biggest Growth Potential in 2019

    By Meagan Parrish, Senior Editor

    Although personalized medicines are on the rise, the era of blockbuster drugs is far from over. In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow. In December, Evaluate Pharma released its pharma industry…

    Full Story
  • Curing Batch Record Pain Points

    By Terrance Holbrook, Senior Product Manager, MasterControl

    Industry 4.0 and smart manufacturing are top of mind for manufacturing leaders and analysts alike. Associated with the cloud, big data, machine learning, the Industrial Internet of Things (IIoT) and predictive analytics, this new wave of connected digital technologies offers manufacturers…

    Full Story
  • The Shutdown and the FDA: What Pharma Companies Need to Know

    By Joel M. Wallace and Imron T. Aly, partners, Schiff Hardin

    As the government shutdown stretches on, pharmaceutical companies must manage the partial shutdown of the U.S. Food and Drug Administration (FDA). The longer the shutdown lasts, the more likely that FDA review of applications will be delayed, affecting company launch plans and business…

    Full Story

Latest Products